Anti-inhibitor Coagulant Complex |
Autoplex T; FEIBA VH Immuno |
Recent Blog Posts
View Post: STAT!Ref Weblog: AHFS DI Essentials: What's New in June 2008
23 Jun 2008 by Ed Schumacher
New Monographs Aliskiren: Nonpeptide renin inhibitor. Antithrombin III: Anticoagulant; naturally occurring plasma thrombin inhibitor. Anti-inhibitor Coagulant Complex: Anti-inhibitor coagulant complex, also known as activated ...
View Blog: STAT!Ref Weblog - http://statref.typepad.com/main/
View Post: FDA Sends Letter to Baxter Over 'Clinical Thank You Email' - Drugs ...
30 Jul 2008
Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. Transfusion. 1990; 30: 626-630.3Hilgartner MW, Knatterud LG, and the FEIBA Study Group. The use of factor eight inhibitor by-passing activity ...
View Blog: Drugs.com - Pharma News - http://www.drugs.com/news.html
View Post: Rajasthan Information Commission to review information disclosures ...
17 Jun 2006 by rtiact2005
If these Anti Hemophilia Factor VIII, IX and Anti inhibitor coagulant complex or FEIBA( Factor VIII Inhibiting bye pass activity), are not available in the Government hospitals of Rajasthan, then what is being given to the patients of ...
View Blog: Right2Information - http://right2information.wordpress.com/
View Post: clinical genetics: Treatment of genetic diseases: in the real ...
21 Nov 2007 by praspowt
Anti-Inhibitor Coagulant Complex FEIBA from Baxter (can be used in both types) In mild hemophilia A or hemophiliac patients undegoing to perform oral procedure: transamin (tranexamic acid) from Daiichi. เขียนโดย praspowt ที่ 15:58 ...
View Blog: clinical genetics - http://clinicalgenetics.blogspot.com/
View Post: Medical Abbreviations and prefix/suffix medical terms
31 May 2008 by Bill Dunbar
... AHP: Accountable Health Partnership; AHP: Accountable Health Plan; AHP: Alternative Health Plan; AHPA: American Health Planning Association; AHRQ: Agency for Healthcare Research & Quality; AICC: Anti-Inhibitor Coagulant Complex ...
View Blog: Bill Dunbar and Associates - http://www.billdunbar.com/
View Post: Critical Care
Full text
Management of bleeding following major ... ...
View Blog: Abildgaard CF, Penner JA, Watson-Williams EJ: Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia. Blood 1980, 56:978-984. PubMed Abstract OpenURL. Menache D: Report on the task force on the
View Post: ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti ...
15 Nov 2009 by Thrombogenics Nv
BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer. ThromboGenics has built strong links with the University of. Leuven and the Flanders Institute for .... oral dosing part of its ongoing phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717,an insulin-like growth factor-1 (IGF-1) receptor inhibitor which has no effects on the closely related insulin receptor. ...
View Blog: PR Hub - http://blog.taragana.com/pr/
View Post: Arthritis Research & Therapy
Full text
Association between ... ...
View Blog: McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
View Post: Thrombosis Journal
Full text
Annexin V and anti-Annexin V ... ...
View Blog: Furthermore, ANV has been shown to be an effective inhibitor of thrombus formation in a venous and arterial thrombus model and in vitro perfusion models. [9,10]. ANV binds to the phosphatidylserine inhibiting the pro-coagulant and pro- inflammatory ... The complex of phosphatidylserine and extracellular ANV provides an antigenic stimulation for antibody production. Anti-annexin V antibodies (aANVAs) were detected in various abnormalities like rheumatoid arthritis (RA),

Not Signed In -

